| |
0-2 year
|
|---|
| |
T2T (n=261)
|
UC (n=213)
| |
UC from 2006 (n=69)
| |
|---|
| |
Volume
|
Costs
|
Volume
|
Costs
|
Difference in costs
|
Volume
|
Costs
|
Difference in costs
|
|---|
|
Consultations rheumatologist
|
10.4 ± 3.0
|
696 ± 199
|
10.3 ± 2.9
|
689 ± 195
|
7
|
10.2 ± 3.6
|
683 ± 239
|
13
|
|
Consultations nurse
|
8.8 ± 3.0
|
588 ± 200
|
7.8 ± 1.9†
|
522 ± 127†
|
66
|
6.6 ± 2.0†
|
438 ± 134†
|
150
|
|
Telephonic consultations
|
1.3 ± 1.8
|
34 ± 46
|
0.6 ± 1.4†
|
16 ± 36†
|
18
|
1.1 ± 1.9
|
29 ± 48
|
5
|
|
Hospital admissions
|
0.4 ± 2.7
|
178 ± 1,208
|
1.1 ± 4.2†
|
521 ± 1,901†
|
-343
|
0.3 ± 1.6
|
158 ± 714
|
20
|
|
Medication
| | | | | | | | |
|
DMARDs/other
| |
174 ± 165
| |
249 ± 340
|
-75
| |
166 ± 119
|
8
|
|
Anti-TNF
| |
3,121 ± 7,162
| |
1,730 ± 4,905†
|
1,391
| |
1,877 ± 5,086
|
1244
|
|
Total
| |
4,791 ± 7,436
| |
3,727 ± 5,773
|
1,064 (1,026 to 1,121)‡
| |
3,351 ± 5,179†
|
1440 (1,387 to 1479)‡
|
| |
0-3 year
|
| |
T2T (n=127)
|
UC (n=180)
| |
UC from 2006 (n=45)
| |
| |
Volume
|
Costs
|
Volume
|
Costs
|
Difference in costs
|
Volume
|
Costs
|
Difference in costs
|
|
Consultations rheumatologist
|
13.7 ± 3.3
|
917 ± 220
|
13.6 ± 3.3
|
909 ± 224
|
8
|
12.5 ± 3.8
|
838 ± 253†
|
79
|
|
Consultations nurse
|
12.1 ± 3.6
|
809 ± 244
|
8.9 ± 1.7†
|
596 ± 117†
|
213
|
8.4 ± 2.2†
|
565 ± 145†
|
244
|
|
Telephonic consultations
|
1.9 ± 2.1
|
49 ± 54
|
0.8 ± 1.7†
|
21 ± 45†
|
28
|
1.7 ± 2.5
|
43 ± 64
|
6
|
|
Hospital admissions
|
0.5 ± 3.2
|
215 ± 1,441
|
1.6 ± 5.0†
|
748 ± 2,263†
|
-533
|
0.8 ± 2.7
|
364 ± 1,217
|
-149
|
|
Medication
| | | | | | | | |
|
DMARDs/other
| |
260 ± 335
| |
423 ± 612†
|
-163
| |
259 ± 174
|
1
|
|
Anti-TNF
| |
4,160 ± 10,685
| |
4,175 ± 10,070
|
-15
| |
5,488 ± 11,528
|
-1,328
|
|
Total
| |
6,410 ± 10,845
| |
6,872 ± 11,033
|
-462 (-513 to -350)‡
| |
7,558 ± 11,649
|
-1,148 (-1241 to -1075)‡
|
- Volumes are the mean ± standard deviation (SD).
- Anti-TNF, anti-tumour necrosis factor; CI, confidence interval; DMARDs, disease-modifying antirheumatic drugs.
- † P < 0.05 for differences between groups (T2T versus UC). ‡ 95% confidence interval bootstrapped.
